首页 银休特(usPODD)-基本信息

银休特(usPODD)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:283.22

最高价:287.29

成交量:214137.0

昨收价:284.56

最低价:280.44

最新价:287.13

行情图标
概要信息

中文名称:银休特


英文名称:Insulet


行业:医疗


简介:Insulet Corporation是于2000年成立的一家特拉华州的公司


电话:1-978-6007000


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

Insulet Corporation提供OmniPod Insulin Management System (OmniPod System),系统包括:OmniPod,一种易于使用的胰岛素依赖性糖尿病患者的连续胰岛素输送系统;个人糖尿病管理器,一种手持无线设备。Insulet Corporation还销售血糖测试用品,胰岛素泵,泵用品,药品和其他产品,用于糖尿病的管理和治疗。Insulet Corporation通过直接销售代表和独立分销商销售其OmniPod System。

交易日期 交易人 职位 类型 交易份额 价格
2019-06-12 Spears (Michael P) Officer Sell 496 117.98
2019-06-12 Spears (Michael P) Officer Buy 2000 29.26
2019-06-04 Petrovic (Shacey) Chief Executive Officer Sell 895 113.00
2019-06-02 Budden (Lauren) Officer Buy 3721 --
2019-05-30 Crawford (Sally W.) Director Buy 2000 20.90
2019-05-30 Crawford (Sally W.) Director Buy 5235 28.87
2019-05-30 Crawford (Sally W.) Director Buy 4000 35.11
2019-05-30 Crawford (Sally W.) Director Buy 4000 30.04
2019-05-30 Crawford (Sally W.) Director Buy 5525 27.37
2019-05-30 Crawford (Sally W.) Director Buy 4000 17.75
2019-05-30 Crawford (Sally W.) Director Buy 3587 40.60
2019-05-30 Crawford (Sally W.) Director Sell 28347 108.60
2019-05-29 Scannell (Timothy J.) Director Buy 1726 --
2019-05-29 Nevinny (Corinne H) Director Buy 1726 --
2019-05-29 Minogue (Michael R) Director Buy 1726 --
2019-05-29 Lemoine (David A) Director Buy 1726 --
2019-05-29 Hopfield (Jessica) Director Buy 1726 --
2019-05-29 Fallon John A Director Buy 1726 --
2019-05-29 Crawford (Sally W.) Director Buy 1726 --
2019-05-23 Christensen (Brett) Officer Sell 687 108.57
2019-05-15 Lemoine (David A) Director Buy 8752 26.00
2019-05-15 Lemoine (David A) Director Sell 8752 106.92
2019-05-14 Lemoine (David A) Director Sell 874 102.49
2019-05-14 Alpuche (Charles) Chief Operating Officer Sell 3900 104.78
2019-04-01 Colleran (David B J.D.) General Counsel Buy 7395 30.98

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Artisan Partners Limited Partnership 1391041 2.31% 207780 17.56% 2019-03-31
Fidelity Management & Research Company 4779264 7.93% -129629 -2.64% 2019-07-31
PRIMECAP Management Company 4919472 8.16% 43214 0.89% 2019-03-31
Vanguard Group Inc 5260092 8.73% 70940 1.37% 2019-03-31
Capital Research Global Investors 5268442 8.74% 977623 22.78% 2019-03-31
Capital Research and Management Company 6606774 10.96% -55300 -0.83% 2019-07-31
Fidelity Management and Research Company 8714160 14.46% 36530 0.42% 2019-03-31
Wellington Management Company LLP 7410810 12.30% -754037 -9.24% 2019-03-31
FMR Inc 8821151 14.64% 30262 0.34% 2019-03-31
Fidelity SelectCo, LLC 2970648 4.93% -33800 -1.12% 2019-07-31
BlackRock Fund Advisors 2894342 4.80% 20460 0.71% 2019-07-31
BlackRock Inc 2805985 4.66% -77895 -2.70% 2019-03-31
Fidelity Management Trust Co 1427185 2.37% 1491 0.10% 2019-07-31
Vanguard Investments Australia Ltd 1643142 2.73% 908 0.06% 2019-07-31
Fred Alger Management Inc 1845127 3.06% 193601 11.72% 2019-03-31
ClearBridge Advisors, LLC 1913428 3.17% 33828 1.80% 2019-03-31
Frontier Capital Management CO Inc 1958736 3.25% 214033 12.27% 2019-03-31
Vanguard 1961530 3.25% -156575 -7.39% 2019-07-31
William Blair Investment Management, LLC 2144988 3.56% 290790 15.68% 2019-03-31
Hartford Funds Management Company, LLC 2375137 3.94% -15914 -0.67% 2019-07-31
D. E. Shaw & Co LP 1385529 2.34% -39450 -2.77% 2018-12-31
OppenheimerFunds Inc 1305555 2.20% 234221 21.86% 2018-12-31
OFI Global Asset Management, Inc. 1213621 2.05% 51246 4.41% 2019-01-31
Legg Mason Partners Fund Advisor, LLC 1187494 2.01% 29890 2.58% 2018-12-31
BlackRock Institutional Trust Company NA 1575736 2.67% -68369 -4.16% 2018-06-30
Champlain Investment Partners, LLC 925215 1.57% -115960 -11.14% 2018-06-30
Lord, Abbett & Co LLC 1035311 1.76% -173550 -14.36% 2018-06-30
State Street Corp 884271 1.50% -298579 -25.24% 2018-06-30
AEGON Scottish Equitable 907505 1.54% -101391 -10.05% 2018-07-31
Renaissance Technologies Corp 814500 1.38% -183000 -18.35% 2018-06-30
Capital World Investors 714000 1.21% 414000 138.00% 2018-06-30
Northern Trust Investments N A 759511 1.29% -2284 -0.30% 2018-03-31
Wells Capital Management Inc. 684859 1.17% 5041 0.74% 2018-03-31
Think Investments LP 691300 1.18% -- -- 2018-03-31
Arrowpoint Asset Management, LLC 624839 1.06% 141 0.02% 2018-03-31
Millennium Management LLC 941567 1.61% 571082 154.14% 2017-12-31
Deerfield Management Co 705573 1.21% 208573 41.97% 2017-12-31
NORGES BANK 680980 1.17% -305295 -30.95% 2017-12-31
Valinor Management, LLC 1230819 2.12% -483146 -28.19% 2017-09-30
Slate Path Capital LP 2720000 4.68% -75000 -2.68% 2017-09-30
Wells Fargo Funds Management LLC 493594 0.85% -400 -0.08% 2017-11-30
Point72 Asset Management, L.P. 605900 1.04% 605900 -- 2017-09-30
Loomis Sayles & Company LP 605869 1.06% -27562 -4.35% 2016-09-30
Janus Capital Management LLC 587421 1.02% -1993 -0.34% 2016-09-30
BlackRock, Inc. 3358285 2.00% 99942562 0.10% 1999-11-30
The Vanguard Group, Inc. 3444306 2.00% 102502547 0.10% 1999-11-30
Wellington Management Group LLP 4146103 2.00% 123388025 0.10% 1999-11-30
FMR LLC 5066103 2.00% 150767225 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Fidelity 582669 0.97% -1236 -0.21% 2019-04-30
American Funds SMALLCAP World Fund 4696019 7.79% -46300 -0.98% 2019-06-30
PrimeCap Odyssey Growth Fund 2506021 4.16% -86500 -3.34% 2019-06-30
PrimeCap Odyssey Aggressive Growth Fund 1734056 2.88% -263900 -13.21% 2019-06-30
Vanguard Explorer Fund 1702208 2.82% 13454 0.80% 2019-03-31
Vanguard Total Stock Market Index Fund 1629124 2.70% 297 0.02% 2019-06-30
Vanguard Small Cap Index 1525969 2.53% -15011 -0.97% 2019-06-30
Fidelity Growth Company Commingled Pool 1413286 2.34% -- -- 2019-06-30
Hartford Growth Opportunities Fund 1066774 1.77% -- -- 2019-06-30
American Funds IS 1045455 1.73% -9000 -0.85% 2019-06-30
ClearBridge Small Cap Growth Fund 1039115 1.72% -- -- 2019-06-30
Vanguard Small Cap Growth Index Fund 874323 1.45% 917 0.10% 2019-06-30
Vanguard Health Care Fund 866435 1.44% -- -- 2019-03-31
American Funds New Economy Fund 865300 1.44% -- -- 2019-06-30
Vanguard Extended Market Index Fund 819810 1.36% 793 0.10% 2019-06-30
Alger Small Cap Focus Fund 735313 1.22% 46833 6.80% 2019-05-31
William Blair Small-Mid Cap Growth Fund 638567 1.06% 6400 1.01% 2019-06-30
Vanguard Small Cap Index Fund 1543370 2.59% 10956 0.71% 2019-04-30
iShares Russell 2000 Growth ETF 584334 0.99% 1008 0.17% 2018-06-21
VA CollegeAmerica The New Economy Fd 604300 1.02% 25000 4.32% 2018-12-31
VA CollegeAmerica SMALLCAP Wld Fd 3757400 6.34% 123977 3.41% 2018-12-31
Oppenheimer Discovery Fund 573020 0.97% 31570 5.83% 2018-12-31
Wells Fargo Discovery Fund 519095 0.88% 24900 5.04% 2018-10-31
ClearBridge Small Cap Growth A 1018913 1.73% 11060 1.10% 2018-07-31
Oppenheimer Discovery A 497210 0.84% 38000 8.28% 2018-07-31
Alger Small Cap Focus A 523687 0.89% 84335 19.20% 2018-06-30
VA CollegeAmerica New Economy 529F 740000 1.25% -- -- 2018-06-30
VA CollegeAmerica Smcap World 529E 3696897 6.27% -73703 -1.95% 2018-06-30
PRIMECAP Odyssey Growth 2614521 4.43% -- -- 2018-06-30
PRIMECAP Odyssey Aggressive Growth 1964956 3.33% -- -- 2018-06-30
Vanguard Explorer Inv 1653167 2.80% 32010 1.97% 2018-06-30
Vanguard Total Stock Mkt Idx 1476885 2.50% 1518 0.10% 2018-07-31
Champlain Small Company Fund 730735 1.24% 32850 4.71% 2018-08-31
Hartford Growth Opportunities A 911787 1.55% 129351 16.53% 2018-07-31
Vanguard Small Cap Growth Index Inv 843887 1.43% 12553 1.51% 2018-07-31
Fidelity Advisor 756224 1.29% -4996 -0.66% 2018-04-30
Vanguard Extended Market Idx Inv 777767 1.32% 3600 0.47% 2018-07-31
Lord Abbett Developing Growth A 504528 0.86% -- -- 2018-06-30
Wells Fargo Discovery Admin 452395 0.77% -- -- 2018-05-31
JHFunds2 Mid Cap Stock 1 504861 0.86% -15081 -2.90% 2018-04-30
iShares Russell 2000 Growth 584334 1.03% 1008 0.17% 2018-06-21
Hartford Small Company HLS IA 532060 0.93% 73273 15.97% 2016-12-31
Janus Venture D 532908 0.93% -2846 -0.53% 2016-12-31
Fidelity® Growth Company Fund 1718900 3.00% -18800 -1.10% 2015-09-30
VA CollegeAmerica New Economy 1413400 2.50% -- -- 2015-09-30
Champlain - Small Cap Equity Tr 1381300 2.40% 122075 9.70% 2015-06-30
iShares Russell 2000 (AU) 900204 1.80% -567 -0.10% 2015-11-18
John Hancock II Mid Cap Stock Fund 656807 1.10% 14167 2.20% 2015-09-30
Hartford Small Company HLS Fund 625059 1.10% -- -- 2015-09-30
Meridian Growth Fund® 614764 1.10% 193329 45.90% 2015-09-30
VA CollegeAmerica Small Cap World 2374000 4.20% 437200 22.60% 2015-09-30

Michael R. Minogue Michael R. Minogue is a businessperson who founded Mentoring Veterans Program and who has been at the helm of 5 different companies. Currently, Mr. Minogue is Chairman, President & Chief Executive Officer at ABIOMED, Inc. He is also on the board of Insulet Corp., Advanced Medical Technology Association and Medical Device Innovation Consortium (former Chairman) and Chairman of Mentoring Veterans Program. Michael R. Minogue previously occupied the position of Chairman of Massachusetts Medical Device Industry Council, Vice President, GM-Americas Sales & Marketing at General Electric Co. and Vice President, GM-Americas Sales & Marketing at GE Medical Systems Information Technologies, Inc. (a subsidiary of General Electric Co.) and Chief Executive Officer of ABIOMED Europe GmbH. He received an undergraduate degree from US Military Academy and an MBA from The University of Chicago.
Timothy J. Scannell Presently, Timothy J. Scannell occupies the position of Independent Chairman for Insulet Corp. He is also President & Chief Operating Officer for Stryker Corp. In his past career Mr. Scannell occupied the position of Vice President & General Manager at Stryker Biotech LLC and Vice President & General Manager at Stryker Spine. Mr. Scannell received an undergraduate degree and an MBA from the University of Notre Dame.
Timothy J. Scannell Presently, Timothy J. Scannell occupies the position of Independent Chairman for Insulet Corp. He is also President & Chief Operating Officer for Stryker Corp. In his past career Mr. Scannell occupied the position of Vice President & General Manager at Stryker Biotech LLC and Vice President & General Manager at Stryker Spine. Mr. Scannell received an undergraduate degree and an MBA from the University of Notre Dame.
Shacey Petrovic Shacey Petrovic is on the board of InPress Technologies, Inc. and President, Chief Executive Director & Director at Insulet Corp. In her past career Ms. Petrovic occupied the position of President & Chief Executive Officer of Clinical Innovations LLC and Vice President & GM-GYN Surgical Products Division at Hologic, Inc. and Vice President & GM-GYN Surgical Products Division at Cytyc Corp. (a subsidiary of Hologic, Inc.). Shacey Petrovic received an undergraduate degree from the University of Wisconsin.
James C. Mullen James C. Mullen is a businessperson who has been at the head of 11 different companies and occupies the position of Chairman at Torque Therapeutics, Inc., Chairman for Editas Medicine, Inc., Non-Executive Chairman at Percivia LLC and Chief Executive Officer of DPx Holdings BV. Mr. Mullen is also on the board of Insulet Corp., Thermo Fisher Scientific, Inc. and The Rivers School Corp. and Member of Biomedical Sciences Careers Program, Inc. In the past he held the position of Chairman at Biotechnology Innovation Organization, Executive Chairman at Vicarius Pharma AG, President & Chief Executive Officer for Biogen, Inc. Director at Biogen Idec, Inc. (North Carolina) and President at Biogen Idec New Ventures, Inc. (both are subsidiaries of Biogen, Inc.), Chief Executive Officer & Non-Independent Director at Patheon, Inc., Chief Executive Officer & Executive Director at Patheon NV and Principal at GlaxoSmithKline LLC. James C. Mullen received an MBA from Villanova University and an undergraduate degree from Rensselaer Polytechnic Institute.
Patrick J. Sullivan Mr. Patrick J. Sullivan is Founder & Managing Partner at Constitution Medical Investors, Inc. and Independent Director at PerkinElmer, Inc. (United States). He is on the Board of Directors at Gen-Probe, Inc., PerkinElmer, Inc. (United States), and Catalina Lighting, Inc. Prior to co-founding Constitution Medical Investors with Daniel Levangie in June 2008, Mr. Sullivan had been Chief Executive Officer and a Director of Cytyc Corp. Mr. Sullivan held various senior marketing positions for 5 years at Abbott Laboratories. He has also served Executive Chairman and a Director of Hologic, Inc. Mr. Sullivan graduated from the United States Naval Academy and received an MBA from Harvard University. Mr. Sullivan is a Director of PerkinElmer, Inc.
Daniel J. Levangie Mr. Daniel J. Levangie is President-Drug Delivery Division at Insulet Corp. He is on the Board of Directors at Dune Medical Devices Ltd., EXACT Sciences Corp., CereVasc LLC and Constitution Medical, Inc. Mr. Levangie was previously employed as an Independent Director by LipoScience, Inc., Chairman by Keystone Dental, Inc., Co-Founder & Managing Partner by Constitution Medical Investors, Inc., Non-Executive Chairman by ev3, Inc., President, Chief Commercial Officer & EVP by CYTYC Surgical Products, President, Chief Executive & Operating Officer by Cytyc Health Corp., Executive Vice President by Cytyc Corp., a Principal by Abbott Laboratories, Managing Partner by Aton Partners LLC, a Trustee by Excel Academy Charter School, and Chairman by HyperMed, Inc. He also served on the board at Hologic, Inc. He received his undergraduate degree from Northeastern University.
Sally W. Crawford Sally W. Crawford founded Healthsource, Inc. She is on the board of Hologic, Inc. and 6 other companies. In the past she held the position of Chief Operating Officer at Healthsource, Inc., Marketing Director of Matthew Thornton Health Plan, Inc. and Marketing Director of Beacon Health. Ms. Crawford received an undergraduate degree from Smith College and a graduate degree from Boston University.
John W. Kapples John W. Kapples occupies the position of Secretary, General Counsel & SVP at Insulet Corp., Secretary, Director & Vice President at VNUS Medical Technologies, Inc., Secretary, Director & Vice President at Somanetics Corp. and Secretary & Director at United States Surgical Corp. Mr. Kapples is also Member of Society for Corporate Governance, Inc. and Member of Massachusetts Bar Association. In his past career he held the position of Associate of Sullivan & Worcester LLP, Vice President of Medtronic Plc Secretary & Vice President at Covidien Plc, Secretary, Director & Vice President at ev3, Inc. Secretary & Vice President for Power Medical Interventions, Inc. Secretary, Director & Vice President at Aspect Medical Systems, Inc. Secretary & Vice President at Covidien Holding, Inc. and Secretary & Director at B�0�1�6�5RRX Medical, Inc. (which are all subsidiaries of Medtronic Plc), Secretary, Vice President & General Counsel for GCP Applied Technologies, Inc., Secretary of Raytheon Co. and Vice President & General Counsel at W.R. Grace & Co. John W. Kapples received an undergraduate degree and a graduate degree from Georgetown University and a graduate degree from Georgetown University Law Center.
John A. Fallon Founder of North Shore Health System, John A. Fallon is a businessperson who has been at the helm of 5 different companies is Chairman of New England Healthcare Institute and on the board of 6 other companies. In the past he occupied the position of President & Chief Executive Officer for North Shore Health System, Chief Executive Officer of Charter Professional Services Corp., Chief Medical Officer of North Shore Medical Center, Inc., Chairman at Partners HealthCare System, Inc., Chief Executive Officer-Clinical Affairs at State University of New York at Downstate Medical Center, Chief Executive Officer-Clinical Affairs at The State University of New York, Senior Vice President at Blue Cross & Blue Shield of Massachusetts, Inc. and Chairman-Medical Standards at National Committee for Quality Assurance. He received an undergraduate degree from College of the Holy Cross (Massachusetts), an MBA from the University of South Florida and a doctorate from Tufts University School of Medicine.
Wayde McMillan Presently, Wayde McMillan is Chief Financial Officer of Insulet Corp. He previously was CFO & Vice President-Finance at Medtronic Plc and Chief Financial Officer & VP-Finance at Covidien Plc (a subsidiary of Medtronic Plc). He received an undergraduate degree from Merrimack College and an MBA from McCallum Graduate School of Business.
David A. Lemoine David A. Lemoine is on the board of The L.S. Starrett Co. and Insulet Corp. and Member of Massachusetts Society of Certified Public Accountants, Inc. and Member of The American Institute of Certified Public Accountants. In his past career he occupied the position of Senior Vice President-Finance & Administration at Briox Technologies, Inc., Principal at SkillMaster Staffing Services, Inc. and Audit Partner at Deloitte & Touche LLP. He received an undergraduate degree from Boston College and a graduate degree from Northeastern University.
Deborah R. Gordon Currently, Deborah R. Gordon is VP-Investor Relations & Communications at Insulet Corp. Ms. Gordon previously occupied the position of Vice President-Investor Relations at Hologic, Inc. Director-Technical Accounting & SEC Reporting at Cytyc Corp. and Vice President-Investor Relations for Third Wave Technologies, Inc. (both are subsidiaries of Hologic, Inc.). She received an undergraduate degree from Clark University.
Corinne H. Nevinny Currently, Corinne H. Nevinny is President & Chief Financial Officer at Fight 2 B Fit, Inc. Ms. Nevinny is also on the board of Restorsea Holdings LLC, Insulet Corp., United States Olympic Committee and Restorsea LLC and General Partner at LMNVC, LLC. In the past Ms. Nevinny held the position of President-Global Operations & Vice President at Edwards Lifesciences Corp., Chief Financial Officer & Vice President for Tularik, Inc., Senior Vice President-Investment Banking at PaineWebber, Inc. and Executive Director-Health Care Group at Warburg Dillon Read LLC. Corinne H. Nevinny received an undergraduate degree from Stanford University, an MBA from Harvard University and an MBA from Harvard Business School.
James Hollingshead Dr. James Hollingshead is a President-Sleep Business at ResMed, Inc. He is on the Board of Directors at Insulet Corp. and Consumer Sleep Solutions LLC. Dr. Hollingshead was previously employed as a Senior Partner by Deloitte Consulting LLP and a Managing Partner-West Coast Division by The Monitor Group, Inc. He received his undergraduate degree from Stanford University, a graduate degree from the University of California, Berkeley and a doctorate degree from the University of California, Berkeley.
Shacey Petrovic Shacey Petrovic is on the board of InPress Technologies, Inc. and President, Chief Executive Director & Director at Insulet Corp. In her past career Ms. Petrovic occupied the position of President & Chief Executive Officer of Clinical Innovations LLC and Vice President & GM-GYN Surgical Products Division at Hologic, Inc. and Vice President & GM-GYN Surgical Products Division at Cytyc Corp. (a subsidiary of Hologic, Inc.). Shacey Petrovic received an undergraduate degree from the University of Wisconsin.
Jessica Hopfield Dr. Jessica Hopfield is an Independent Director at Editas Medicine, Inc., an Independent Director at Insulet Corp. and a President at J Hopfield Consulting LLC. She is on the Board of Directors at Radius Health, Inc., Editas Medicine, Inc., Insulet Corp. and Joslin Diabetes Center. Dr. Hopfield was previously employed as a Partner by McKinsey & Co., Inc. She also served on the board at rEVO Biologics, Inc. She received her undergraduate degree from Yale College, an MBA from Harvard Business School and a doctorate degree from The Rockefeller University.
Philip Hildale Presently, Philip Hildale is Senior Vice President-Sales & Customer Care at Insulet Corp. In the past Mr. Hildale held the position of Vice President-Sales of LipoScience, Inc.
Christopher Gilbert Presently, Christopher Gilbert occupies the position of Vice President-Marketing for Insulet Corp.
Daniel Trodden Daniel Trodden is Vice President-Managed Care at Insulet Corp.
Annette Brewster Annette Brewster is Vice President-Customer Care at Insulet Corp.
Shacey Petrovic Shacey Petrovic is on the board of InPress Technologies, Inc. and President, Chief Executive Director & Director at Insulet Corp. In her past career Ms. Petrovic occupied the position of President & Chief Executive Officer of Clinical Innovations LLC and Vice President & GM-GYN Surgical Products Division at Hologic, Inc. and Vice President & GM-GYN Surgical Products Division at Cytyc Corp. (a subsidiary of Hologic, Inc.). Shacey Petrovic received an undergraduate degree from the University of Wisconsin.
Michael P. Spears Currently, Michael P. Spears holds the position of SVP-Quality & Regulatory Affairs at Insulet Corp. He previously was Vice President- Quality Assurance at Covidien Holding, Inc. Mr. Spears received an undergraduate degree from the University of Tennessee and an MBA from the University of South Carolina.
Charles Alpuche Currently, Charles Alpuche is Chief Operations Officer & Executive VP at Insulet Corp. Mr. Alpuche is also on the board of Delaware Valley University. In his past career he was Senior Vice President of PepsiCo Beverages & Foods North America. He received an undergraduate degree from Delaware Valley University and a graduate degree from the University of Pennsylvania.
Aiman Abdel-Malek Presently, Aiman Abdel-Malek occupies the position of Chief Technology Officer & Executive VP at Insulet Corp. In his past career he was President at Frictionless Life Analytics, Inc., Vice President-Engineering of QUALCOMM, Inc. and General Manager-Global Services Technology at General Electric Healthcare Technologies, Inc. He received an undergraduate degree from the University of Cairo and a doctorate from the University of Southern California.
Brittany Bradrick Brittany Bradrick is Vice President-Strategy & Corporate Development at Insulet Corp. Ms. Bradrick received an undergraduate degree from the University of Missouri and an MBA from Johnson Graduate School of Management.
Trang Ly Trang Ly is Vice President & Medical Director at Insulet Corp. In the past Dr. Ly was Clinical Assistant Professor at Stanford University School of Medicine. Dr. Ly received an undergraduate degree and a doctorate from The University of Western Australia.
Bret Christensen Bret Christensen is Chief Commercial Officer & Executive VP for Insulet Corp. In the past he was General Manager-Preventive Care at Myriad Genetics, Inc. and VP-Gynecologic Sales & Marketing at Hologic, Inc. Mr. Christensen received an undergraduate degree and an MBA from Utah Valley University and an MBA from the University of Utah.
Eric Benjamin Eric Benjamin is Senior Vice President-Research & Development at Insulet Corp.
Lauren Budden Presently, Lauren Budden occupies the position of Chief Accounting Officer, Controller & VP at Insulet Corp. Ms. Budden received an undergraduate degree from Boston College and an MBA from the University of Massachusetts.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐